Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Jonathan S. Jaffe"'
Publikováno v:
Sexual Medicine, Vol 3, Iss 4, Pp 269-279 (2015)
Introduction: Hypogonadism is one of the most common male endocrine problems. Although many treatments are currently available, unmet need exists for new testosterone (T) replacement therapies that are simple to administer and use, are safe, and mimi
Externí odkaz:
https://doaj.org/article/d756ef45fa8846b8b8b8f56f74048199
Publikováno v:
Journal of the Endocrine Society. 7
Context Intramuscular (IM) testosterone enanthate (TE) and testosterone pellets were US Food and Drug Administration approved before 1962 for pediatric use but not studied in controlled trials in adolescents. Objective An analysis using nonlinear mix
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8433342462177e43b4cbf52f9a0de536
https://doi.org/10.1210/jendso/bvad059
https://doi.org/10.1210/jendso/bvad059
Autor:
James P Tursi, Jonathan S. Jaffe, David Schofield, Marc Gittelman, Martin Miner, Alexander W. Pastuszak
Publikováno v:
Andrology. 10(2)
Background To improve symptoms associated with testosterone deficiency, many testosterone therapies are available that aim to restore serum testosterone (T) levels to the normal physiologic range. The magnitude, frequency, and duration between peak a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc5083669d1b46e1671b56a43aa18fa2
https://pubmed.ncbi.nlm.nih.gov/34510812
https://pubmed.ncbi.nlm.nih.gov/34510812
Publikováno v:
The Journal of Sexual Medicine. 16:1741-1748
Introduction Patients with testosterone deficiency (TD) can be treated with exogenous testosterone (T) to achieve and maintain physiologic T levels and prevent negative clinical symptoms; with many testosterone replacement therapies currently availab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::999bbee607146168ed52ec81794e10a4
https://doi.org/10.1016/j.jsxm.2019.08.013
https://doi.org/10.1016/j.jsxm.2019.08.013
Publikováno v:
Journal of the Endocrine Society
Testosterone replacement therapy (TRT) is routinely prescribed in adolescent males with constitutional delay of growth and puberty (CDGP) or hypogonadism. With many new testosterone (T) formulations entering the market targeted for adults, we review
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8c78e847c3325dea6e6c00978758cfa
https://doi.org/10.1210/jendso/bvaa161
https://doi.org/10.1210/jendso/bvaa161
Publikováno v:
The journal of sexual medicine. 18(1)
Background Treatment of “adult-onset hypogonadism” (AOH) with exogenous testosterone therapy (TTh) to raise serum testosterone (T) levels may influence cardiovascular (CV) risk factors in patients with AOH, whereas low endogenous T levels are ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90b73dcda005cc34b21ed161ee9778d1
https://pubmed.ncbi.nlm.nih.gov/33317996
https://pubmed.ncbi.nlm.nih.gov/33317996
Publikováno v:
Journal of the Endocrine Society
BACKGROUND: In men, obesity is often associated with low testosterone (T) levels, but information is limited as to how body weight affects the pharmacokinetic profile or dosing of testosterone therapy (TTh) in men with T deficiency. Historically, men
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5663b3405ebc1a1dc90446a2633cd4d5
https://doi.org/10.1210/jendso/bvaa046.454
https://doi.org/10.1210/jendso/bvaa046.454
Publikováno v:
The Journal of Sexual Medicine. 15:1707-1715
Background The subcutaneous testosterone enanthate (TE) autoinjector (SCTE-AI) is a single-use, pre-filled, disposable autoinjector intended for testosterone (T) self-administration in adult males with T deficiency. Aim To evaluate the usability of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3aa79fd9da71cc48c0ec5f38e77d941
https://doi.org/10.1016/j.jsxm.2018.09.017
https://doi.org/10.1016/j.jsxm.2018.09.017
Autor:
Alexander W. Pastuszak, Martin Miner, Jonathan S. Jaffe, Marc Gittelman, D. Schofield, James P. Tursi
Publikováno v:
The Journal of Sexual Medicine. 17:S57-S58
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93f2e9490d38db41025275bdcffd495e
https://doi.org/10.1016/j.jsxm.2019.11.122
https://doi.org/10.1016/j.jsxm.2019.11.122
Autor:
Jonathan S. Jaffe, Martin Miner, Marc Gittelman, James P. Tursi, Mohit Khera, Jed Kaminetsky, Alexander W. Pastuszak
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:The Subcutaneous Testosterone Enanthate Auto-Injector (SCTE-AI) has been designed to safely deliver testosterone (T) by allowing patients with T deficiency to self-admin...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0610f9c29cd97cc7f0e8a8baa7aa73c
https://doi.org/10.1097/01.ju.0000556711.64543.28
https://doi.org/10.1097/01.ju.0000556711.64543.28